Replies to post #7 on TRACON Pharmaceuticals Inc (TCON)

[DewDiligence]

At 12/31/16, TCON had $44.4M in cash, $8.0M in debt, and 16.1M basic shares outstanding.

[DewDiligence]

TCON is not formally presenting at JPM, but they are there for private meetings—hence the new slide deck.